The Director Global HEOR will be part of the Global Value & Access Team collaborating closely with colleagues in Market Access & Pricing, Marketing, Clinical Development, Research and Development, Market Research, Regulatory Affairs, Medical Affairs and Strategic Planning, to deliver critical strategic value evidence generation in support of access to Ipsen’s products spanning early development, launch and mature phases across Oncology, Neuroscience and Rare disease therapeutic areas. The initial assignment will be in the Rare disease area, but future opportunities may involve assignment across other therapeutic areas of Ipsen portfolio.
This is an exciting opportunity for an experienced HEOR professional to leverage strategic and technical understanding of HEOR in an international setting leading value evidence generation on Ipsen product portfolio for payers and other key stakeholders worldwide.
Lead launch readiness and post-launch updates and development of core HEOR/Access deliverables including systematic and targeted literature reviews, burden of illness studies, unmet medical needs, clinical and patient-relevant outcomes, clinical guidelines, comparative effectiveness including evidence synthesis (including indirect treatment comparisons and network meta-analyses), Cost-Effectiveness Analysis models, Budget Impact Analysis models, Global Value Dossiers, Payer/Product Value Propositions, Objection Handlers for Ipsen products.
Support development of pricing policy and market access of the company products.
Work collaboratively with local affiliates and global cross-functional team including but not limited to Global Medical A airs, Global Regulatory Affairs, Clinical, Biostatistics, Public Affairs, Marketing etc.
A post graduate degree in health economics or related quantitative discipline.
At least 8 years’ relevant experience in the field of HEOR in pharma industry, consultancy, or Academia, in an international setting.
Experience working on international HTA submissions.
Strong scientific analysis, interpretative and writing skills.
Knowledge of international health care systems.
Expertise on HEOR from Oncology, Rare Disease and/or Neuroscience including evidence synthesis, cost-effectiveness and budget impact modeling, RWE methodologies for outcomes research and PROs.
Knowledge of trial design and understanding of key clinical, PRO and resource utilization endpoints.
We are committed to creating a workplace where everyone feels heard, valued, and supported; where we embrace “The Real Us”. The value we place on different perspectives and experiences drives our commitment to inclusion and equal opportunities. When we include diverse ways of thinking, we make more thoughtful decisions and discover more innovative solutions. Together we strive to better understand the communities we serve. This means we also want to help you perform at your best when applying for a role with us. If you require any adjustments or support during the application process, please let the recruitment team know. This information will be handled with care and will not affect the outcome of your application.
